Float Short %

5.13

Margin Of Safety %

Put/Call OI Ratio

1.25

EPS Next Q Diff

1.63

EPS Last/This Y

4.2

EPS This/Next Y

1.16

Price

2.56

Target Price

Analyst Recom

2.33

Performance Q

-29.28

Relative Volume

0.04

Beta

3.41

Ticker: MURA

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-05-09	MURA	2.59	1.85	1.46	39292
2025-05-12	MURA	2.63	1.85	174.38	39980
2025-05-13	MURA	2.67	1.84	0.10	39778
2025-05-14	MURA	2.56	1.84	5.45	39768
2025-05-15	MURA	2.51	1.82	6.08	39879
2025-05-16	MURA	2.64	1.73	0.33	39039
2025-05-19	MURA	2.82	1.39	0.44	23257
2025-05-20	MURA	2.98	1.28	0.91	24939
2025-05-21	MURA	2.77	1.27	0.14	25109
2025-05-22	MURA	2.74	1.26	3.34	25160
2025-05-23	MURA	2.8	1.27	0.17	25420
2025-05-27	MURA	2.63	1.27	2.54	25421
2025-05-28	MURA	2.63	1.27	3.57	25422
2025-05-29	MURA	2.65	1.27	0.00	25554
2025-05-30	MURA	2.62	1.27	0.07	25578
2025-06-02	MURA	2.67	1.26	0.00	25677
2025-06-03	MURA	2.62	1.26	0.00	25677
2025-06-04	MURA	2.58	1.26	0.05	25615
2025-06-05	MURA	2.57	1.26	0.00	25614
2025-06-06	MURA	2.54	1.25	0.01	25692
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-05-09	MURA	2.63	-10.7	-	-5.34
2025-05-12	MURA	2.64	-10.7	-	-5.34
2025-05-13	MURA	2.66	-10.7	-	-5.34
2025-05-14	MURA	2.59	-10.7	-	-5.34
2025-05-15	MURA	2.51	-10.7	-	-5.34
2025-05-16	MURA	2.62	-10.7	-	-5.34
2025-05-19	MURA	2.80	46.2	-	-3.38
2025-05-20	MURA	2.98	46.2	-	-3.38
2025-05-21	MURA	2.76	46.2	-	-3.38
2025-05-22	MURA	2.72	46.2	-	-3.38
2025-05-23	MURA	2.75	46.2	-	-3.38
2025-05-27	MURA	2.63	46.2	-	-3.38
2025-05-28	MURA	2.63	46.2	-	-3.38
2025-05-29	MURA	2.64	46.2	-	-3.38
2025-05-30	MURA	2.62	46.2	-	-3.38
2025-06-02	MURA	2.68	46.2	-	-3.38
2025-06-03	MURA	2.63	46.2	-	-3.38
2025-06-04	MURA	2.58	46.2	-	-3.38
2025-06-05	MURA	2.57	46.2	-	-3.38
2025-06-06	MURA	2.56	46.2	-	-3.38
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-05-09	MURA	-0.73	-3.99	4.08
2025-05-12	MURA	-0.73	-3.70	7.01
2025-05-13	MURA	-0.73	-3.70	7.01
2025-05-14	MURA	-0.73	-3.70	7.01
2025-05-15	MURA	-0.73	-3.70	7.01
2025-05-16	MURA	-0.73	-3.70	7.01
2025-05-19	MURA	-0.73	-5.65	7.00
2025-05-20	MURA	-0.73	-5.65	7.00
2025-05-21	MURA	-0.73	-5.65	7.00
2025-05-22	MURA	-0.73	-5.65	7.00
2025-05-23	MURA	-0.73	-5.65	7.00
2025-05-27	MURA	-0.73	8.32	7.00
2025-05-28	MURA	-0.73	8.32	4.77
2025-05-29	MURA	-0.73	8.32	4.77
2025-05-30	MURA	-0.73	8.32	4.77
2025-06-02	MURA	-0.57	6.18	5.13
2025-06-03	MURA	-0.57	6.18	5.13
2025-06-04	MURA	-0.57	6.18	5.13
2025-06-05	MURA	-0.57	6.18	5.13
2025-06-06	MURA	-0.57	6.18	5.13
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-1.93

Avg. EPS Est. Current Quarter

-1

Avg. EPS Est. Next Quarter

-0.3

Insider Transactions

-0.57

Institutional Transactions

6.18

Beta

3.41

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

84.9

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

0.41

P/Free Cash Flow

EPS

-7.67

Average EPS Est. Cur. Y

-3.38

EPS Next Y. (Est.)

-2.22

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.04

Return on Equity vs Sector %

-145.2

Return on Equity vs Industry %

-127.2

EPS 1 7Days Diff

EPS 1 30Days Diff

1.21

EBIT Estimation

Mural Oncology plc

Sector: Healthcare

Industry: Biotechnology

Employees: 104

Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.

stock quote shares MURA – Mural Oncology plc Stock Price stock today

news today MURA – Mural Oncology plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MURA – Mural Oncology plc yahoo finance google finance

stock history MURA – Mural Oncology plc invest stock market

stock prices MURA premarket after hours

ticker MURA fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: MURA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y